This inventor holds 26 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 17 EPO patents, primarily in NADPH Oxidase Inhibitors. Top assignees: Genkyotex Sa, Merck Serono S. a., Genkyotex Suisse Sa. Active years: 2006-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Savonni, FR (2012 - 2013)
- Saint-Julie-en-Genevois, FR (2013)
- Saint-Julien-en-Genevois, FR (2006 - 2022)
Company Filing History:
13 out of 13 
8 out of 145 
2 out of 3 Years Active: 2006-2022
Areas of Expertise:
Title: Innovations by Patrick Naxos Page: A Pioneer in Pharmaceutical Patents
Introduction: Patrick Naxos Page, a distinguished inventor based in Saint Julien-en Genevois, France, has made significant contributions to the pharmaceutical field with a remarkable portfolio of 26 patents. His innovative work focuses on developing new therapeutics that target critical health issues, particularly in the realm of pregnancy and oxidative stress conditions.
Latest Patents: Among Patrick's latest inventions are two noteworthy patents. The first patent, titled "Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof," details compounds that can inhibit prostaglandin F receptor, with potential applications in treating disorders like preterm labor at early gestational stages. The second patent, related to "Pyrazolo pyridine derivatives as NADPH oxidase inhibitors," introduces derivatives that could be pivotal in treating disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Career Highlights: Throughout his career, Patrick has worked with prominent organizations that underscore his expertise and commitment to innovation. Notably, he has held positions at Genkyotex and Merck Serono, S.A., both of which are esteemed companies in the pharmaceutical industry. His tenure in these organizations has allowed him to push the boundaries of medical science through steadfast research and development.
Collaborations: Collaboration has been at the heart of Patrick's innovative journey. He has worked closely with colleagues like Mike Orchard and Francesca Gaggini, contributing to a dynamic environment that fosters creative solutions and leads to groundbreaking inventions. These partnerships have significantly enriched his research and broadened the impact of his work.
Conclusion: Patrick Naxos Page exemplifies the spirit of innovation in the pharmaceutical sector through his extensive patent portfolio and collaborative efforts. His latest inventions hold promise for treating critical health conditions, showcasing how dedicated inventors like him continue to shape the future of medicine through their groundbreaking contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile